Maxcyte (MXCT) Income from Continuing Operations (2020 - 2026)
Maxcyte (MXCT) posted quarterly Income from Continuing Operations of 4750000.0 for Q1 2026, up 53.71% year-over-year from 3090270.73 in Q1 2025, and up 50.5% quarter-over-quarter from 9596000.0 in Q4 2025.
Maxcyte (MXCT) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Income from Continuing Operations for 7 consecutive years, with 4750000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 53.71% year-over-year to 4750000.0; the TTM figure through Mar 2026 stood at 39119000.0 (up 6.39% YoY), while the FY2025 annual figure was 35258000.0, down 8.58% from the prior year.
- Income from Continuing Operations improved to 4750000.0 in Q1 2026 per MXCT's latest filing, from 9596000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 4750000.0 in Q1 2026 and bottomed at 30812400.0 in Q3 2022.
- Historically, Income from Continuing Operations has averaged 13373888.24 across 5 years, with a median of 10597000.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 1139.94% — and 2023, when it soared 81.56%.
- Maxcyte's Income from Continuing Operations stood at 28623600.0 in 2022, then jumped by 81.56% to 5278000.0 in 2023, then slumped by 100.78% to 10597000.0 in 2024, then rose by 9.45% to 9596000.0 in 2025, then jumped by 50.5% to 4750000.0 in 2026.
- Business Quant data shows MXCT's Income from Continuing Operations at 4750000.0 in Q1 2026, 9596000.0 in Q4 2025, and 12416000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | -8.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.87 Mn |
| Mar 31, 2026 | -4.75 Mn |
| Dec 31, 2025 | -9.60 Mn |
| Sep 30, 2025 | -12.42 Mn |
| Jun 30, 2025 | -12.36 Mn |
| Mar 31, 2025 | -10.26 Mn |
| Dec 31, 2024 | -10.60 Mn |
| Sep 30, 2024 | -11.56 Mn |
| Jun 30, 2024 | -9.38 Mn |
| Mar 31, 2024 | -9.53 Mn |
| Dec 31, 2023 | -5.28 Mn |
| Sep 30, 2023 | -11.25 Mn |
| Jun 30, 2023 | -10.51 Mn |
| Mar 31, 2023 | -10.88 Mn |
| Dec 31, 2022 | -28.62 Mn |
| Sep 30, 2022 | -30.81 Mn |
| Jun 30, 2022 | -10.04 Mn |
| Mar 31, 2022 | -29.52 Mn |
| Dec 31, 2021 | -4.87 Mn |
| Sep 30, 2021 | -2.49 Mn |